Literature DB >> 22059156

Canadian patients with chronic hepatitis B cannot access appropriate drug treatments: a call for change.

Morris Sherman, Samuel S Lee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22059156      PMCID: PMC3206555          DOI: 10.1155/2011/864046

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


× No keyword cloud information.
  25 in total

1.  Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues.

Authors:  Florian van Bömmel; Robert A de Man; Heiner Wedemeyer; Katja Deterding; Jörg Petersen; Peter Buggisch; Andreas Erhardt; Dietrich Hüppe; Kerstin Stein; Jörg Trojan; Christoph Sarrazin; Wulf O Böcher; Ulrich Spengler; Hermann E Wasmuth; Jurrien G P Reinders; Bernd Möller; Peter Rhode; Heinz-Hubert Feucht; Bertram Wiedenmann; Thomas Berg
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

2.  Management of hepatitis B: a longitudinal national survey - impact of the Canadian Hepatitis B Consensus Guidelines.

Authors:  Paul Marotta; Kurt Lucas
Journal:  Can J Gastroenterol       Date:  2010-09       Impact factor: 3.522

3.  Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance.

Authors:  D N Moskovitz; C Osiowy; E Giles; G Tomlinson; E J Heathcote
Journal:  J Viral Hepat       Date:  2005-07       Impact factor: 3.728

4.  HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy.

Authors:  Vito Di Marco; Rosa Di Stefano; Donatella Ferraro; Piero Luigi Almasio; Celestino Bonura; Maria Giglio; Pietro Parisi; Maria Cappello; Giuseppe Alaimo; Antonio Craxì
Journal:  Antivir Ther       Date:  2005

5.  Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population.

Authors:  M Sherman; K M Peltekian; C Lee
Journal:  Hepatology       Date:  1995-08       Impact factor: 17.425

Review 6.  Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature.

Authors:  Herve Mommeja-Marin; Elsa Mondou; M Robert Blum; Franck Rousseau
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

7.  Lamivudine for patients with chronic hepatitis B and advanced liver disease.

Authors:  Yun-Fan Liaw; Joseph J Y Sung; Wan Cheng Chow; Geoffrey Farrell; Cha-Ze Lee; Hon Yuen; Tawesak Tanwandee; Qi-Min Tao; Kelly Shue; Oliver N Keene; Jonathan S Dixon; D Fraser Gray; Jan Sabbat
Journal:  N Engl J Med       Date:  2004-10-07       Impact factor: 91.245

8.  Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B.

Authors:  Maria Buti; Max Brosa; Miguel A Casado; Magdalena Rueda; Rafael Esteban
Journal:  J Hepatol       Date:  2009-05-20       Impact factor: 25.083

9.  Updated definitions of healthy ranges for serum alanine aminotransferase levels.

Authors:  Daniele Prati; Emanuela Taioli; Alberto Zanella; Emanuela Della Torre; Sonia Butelli; Emanuela Del Vecchio; Luciana Vianello; Francesco Zanuso; Fulvio Mozzi; Silvano Milani; Dario Conte; Massimo Colombo; Girolamo Sirchia
Journal:  Ann Intern Med       Date:  2002-07-02       Impact factor: 25.391

10.  A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

Authors:  Ting-Tsung Chang; Robert G Gish; Robert de Man; Adrian Gadano; José Sollano; You-Chen Chao; Anna S Lok; Kwang-Hyub Han; Zachary Goodman; Jin Zhu; Anne Cross; Deborah DeHertogh; Richard Wilber; Richard Colonno; David Apelian
Journal:  N Engl J Med       Date:  2006-03-09       Impact factor: 91.245

View more
  2 in total

1.  Antiviral treatment for treatment-naïve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials.

Authors:  William W L Wong; Petros Pechivanoglou; Josephine Wong; Joanna M Bielecki; Alex Haines; Aysegul Erman; Yasmin Saeed; Arcturus Phoon; Mina Tadrous; Mona Younis; Noha Z Rayad; Valeria Rac; Harry L A Janssen; Murray D Krahn
Journal:  Syst Rev       Date:  2019-08-19

Review 2.  Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog Therapy.

Authors:  Carla Osiowy; Carla Coffin; Anton Andonov
Journal:  Curr Treat Options Infect Dis       Date:  2016-07-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.